• Tech Launch Perspective
    July 22, 2026

    Life sciences enterprises are moving beyond isolated generative AI pilots toward governed, multi-agent workflows that support clinical, commercial, and real-world activities. This shift is increasing demand for platforms that combine regulatory-grade data governance, enterprise interoperability, scalable…
  • Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are experiencing rising data complexities as they scale cloud adoption, modernize data estates, and operationalize AI. In this landscape, undetected data issues, ranging from quality degradation and schema drift to pipeline failures and governance lapses,…